| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.071 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |